Voyager Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VYGR research report →
Companywww.voyagertherapeutics.com
Voyager Therapeutics, Inc. , a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease.
- CEO
- Alfred W. Sandrock Jr.
- IPO
- 2015
- Employees
- 172
- HQ
- Lexington, MA, US
Price Chart
Valuation
- Market Cap
- $214.19M
- P/E
- -1.81
- P/S
- 5.88
- P/B
- 1.22
- EV/EBITDA
- -1.71
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 97.45%
- Op Margin
- -349.16%
- Net Margin
- -319.61%
- ROE
- -55.97%
- ROIC
- -60.90%
Growth & Income
- Revenue
- $40.37M · -49.53%
- Net Income
- $-119,721,000 · -84.18%
- EPS
- $-2.04 · -80.53%
- Op Income
- $-131,844,000
- FCF YoY
- -617.24%
Performance & Tape
- 52W High
- $5.55
- 52W Low
- $2.65
- 50D MA
- $4.00
- 200D MA
- $4.07
- Beta
- 1.26
- Avg Volume
- 691.40K
Get TickerSpark's AI analysis on VYGR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 8, 26 | Quinlan Amy | other | 0 |
| May 8, 26 | Quinlan Amy | other | 50,000 |
| May 8, 26 | Quinlan Amy | other | 28,500 |
| Apr 2, 26 | Sandrock Alfred | sell | 11,511 |
| Apr 1, 26 | Shiferman Gregory L. | other | 50,000 |
| Feb 24, 26 | Swartz Robin | sell | 6,458 |
| Feb 24, 26 | Sandrock Alfred | sell | 14,197 |
| Feb 24, 26 | Jorgensen Nathan D. | sell | 4,668 |
| Feb 24, 26 | Carter Todd Alfred | sell | 4,174 |
| Feb 18, 26 | Swartz Robin | sell | 3,882 |
Our VYGR Coverage
We haven't published any research on VYGR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VYGR Report →